Sun Pharmaceuticals reported INR39.54B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Bharat Petroleum INR 116.87B 19.25B Dec/2025
Cipla INR 9.55B 3B Mar/2026
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sun Pharmaceuticals INR 39.54B 9.94B Mar/2026
UPL INR 35.58B 12.41B Mar/2026